Fiche centre
Yonsei University Health System, Severance Hospital
Seoul — South Korea
Essais liés5clinical trials
VilleSeoullocalisation
PaysSouth Korealocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06757634
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Zastaprazan | Accident vasculaire cérébral | Phase 3 | NCT07730840 | Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | NOT_YET_RECRUITING |
| Ambulatory Holter monitoring | Accident vasculaire cérébral | Non applicable | NCT04624646 | CANDLE-AF — Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke | TERMINATED |
| Arm A: Gedatolisib + Palbociclib + Fulvestrant | Cancer | Phase 3 | NCT06757634 | Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) | RECRUITING |
| Oxaliplatin, 5FU, leucovorin | Cancer | Phase 2 | NCT07062536 | mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line | RECRUITING |
| HyperQure Renal Denervation System | Hypertension | Non applicable | NCT06216808 | A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension | ACTIVE_NOT_RECRUITING |